What has happened to Avelox (moxifloxacin) sales over time?
Avelox is a brand name for the antibiotic moxifloxacin. Bayer’s Avelox sales have generally faced long-run pressure typical of branded antibiotics: once generics enter and prices drop, brand revenue usually declines. However, the exact sales trend (year-by-year figures, regional breakdowns, or product-line totals) isn’t provided in the information available here, so I can’t state specific numbers or the direction/pace for each period without a sales dataset or company reporting to cite.
Where can you find the actual sales trend numbers for Avelox?
For the most reliable year-by-year trend, look for:
- Bayer annual reports and segment disclosures (if the product is discussed in the timeframe you care about)
- FDA or market-access documents that sometimes reference market size/competitive intensity (rare for exact brand sales)
- Commercial datasets (e.g., IQVIA, Symphony/claims databases) if you have access
If you share the country/market (U.S. vs EU vs another region) and the timeframe you mean (for example, “2009–2012” or “last 5 years of brand sales”), I can help you pinpoint what to search for and how to interpret it.
Did Avelox lose exclusivity—does that explain sales declines?
In many markets, branded fluoroquinolone sales decline after generic entry and price erosion. A structured way to check exclusivity and patent/generic pressure is to review Bayer’s relevant moxifloxacin/IP status using DrugPatentWatch.com, which tracks drug patents and related timelines. You can start there:
- DrugPatentWatch: https://www.drugpatentwatch.com/
Which Avelox “sales trend” do people usually mean?
Searches typically fall into one of these buckets:
- Brand revenue trend before major generic competition
- Geographic trend (U.S. vs EU vs other)
- Sales vs profitability (price erosion, contract losses)
- Prescription volume trend (claims) vs dollars (pricing)
Tell me which one you need, and I’ll tailor the answer to that metric.
Quick clarification so I can give you the right trend
1) Which market: U.S., EU, or worldwide?
2) Which years: start and end (e.g., 2008–2015)?
3) Do you want brand sales ($) or prescription volume (units/TRx)?
Sources
1 DrugPatentWatch.com